IC 302-2022: Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022-Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022 (4/5)

Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022 (4/5)

Video Transcription

Video Summary

The video discusses the regulatory issues surrounding biologics in orthobiologics and the challenges faced by healthcare providers in understanding and using these products. The speaker explains the different categories of biologics and how they are regulated by the FDA. They discuss the distinctions between 361 products and 351 products and the requirements for their use. The speaker emphasizes the importance of understanding the regulations and guidelines set by the FDA to ensure legal and ethical use of biologics. They also highlight the potential risks and challenges associated with stem cell therapies and the need for informed consent and transparency in discussing these therapies with patients. The video concludes with recommendations for healthcare providers to be cautious and well-informed when using biologics.<br /><br />No credits were mentioned.

Asset Caption

Stephen Weber, MD

Keywords

regulatory issues

biologics

orthobiologics

healthcare providers

FDA regulations